Skip to main
RSLS
RSLS logo

ReShape Lifesciences (RSLS) Market Capitalization Overview

Market Cap: $5.80M as of Jul 1, 2025

$5.80M
Past Month+$2.18M (59.95%)
As of Jul 1, 2025, ReShape Lifesciences (RSLS) has a market capitalization of $5.80M. Over the past 30 days, its market cap has increased by 82.21%, while in the last 12 months, it has increased by 78.08%.

Market capitalization represents the total value of ReShape Lifesciences as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

ReShape Lifesciences (RSLS) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of ReShape Lifesciences (RSLS) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ReShape Lifesciences (RSLS) Market Cap History

DateMarket CapChange
Jul 1, 2025$5.80M+82.21%
Jun 2, 2025$3.19M+182.12%
May 1, 2025$1.13M-78.68%
Apr 1, 2025$5.29M+564.82%
Mar 3, 2025$795.70K-69.29%
Feb 3, 2025$2.60M-22.15%
Jan 2, 2025$3.33M-15.04%

ReShape Lifesciences (RSLS) End of Year Market Cap History

DateMarket CapChange
2025$5.80M+78.08%
2024$3.26M+277.60%
2023$862.20K-71.69%
2022$3.05M-89.58%
2021$29.25M+150.89%
2020$11.66M

FAQs About ReShape Lifesciences (RSLS) Market Cap

As of Jul 1, 2025, the market capitalization of ReShape Lifesciences (RSLS) is $5.80M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, ReShape Lifesciences’s market capitalization has increased by 59.95%, changing from $3.63M to $5.80M as of Jul 1, 2025.

In the last 3 months, ReShape Lifesciences’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, ReShape Lifesciences’s market capitalization increased from $862.20K in January to $3.26M in December, reflecting a 277.6% change.

In the past five years, ReShape Lifesciences (RSLS) has had a compound annual growth rate (CAGR) of -22.51% in market capitalization. This means its market cap has shrunk at an average rate of -22.51% per year.

ReShape Lifesciences (RSLS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.